Literature DB >> 19863331

Clinical and pathological analysis of malignant carotid body tumour: a report of nine cases.

Wen-Chao Zhang1, Jun-Ping Cheng, Qiang Li, Lun Zhang, Xu-Dong Wang, Matti Anniko.   

Abstract

CONCLUSIONS: Malignant carotid body tumour (MCBT) is a clinically rare disease that often invades the carotid artery and cranial nerves. Diagnosis of malignant tumour should be based on extensive invasion of neighbouring organs and distant metastasis. Extensive resection should be undertaken early. Radiotherapy is effective, whereas chemotherapy is uncertain.
OBJECTIVE: To summarize the clinical pathological and prognostic characteristics of MCBT and explore methods for diagnosis and treatment.
MATERIALS AND METHODS: The study material comprised clinical, pathological, therapeutic and follow-up data concerning nine patients (four males, five females) with MCBT, treated at Tianjin Cancer Hospital between January 1956 and June 2006. The material was analysed retrospectively. Disease duration averaged 6.4 years. Shamblin classification was: one case, type II; 8 cases, type III. All nine patients underwent ultrasound examination, four underwent digital subtraction arteriography (DSA) and three had magnetic resonance angiography (MRA). Five patients underwent preoperative training of compression of the carotid (Matas test). Extensive resection was performed in all nine cases.
RESULTS: The carotid artery was blocked in three patients. In one of these the artery was reconstructed with a vascular prosthesis, while two underwent carotid ligation. Eight patients suffered from a cranial nerve dysfunction (defect) and two suffered postoperatively from a hoarse voice, four had a glossal deviation, five had Horner's syndrome and one had a deviation of the lip angle. One patient had a congestive cough. The histopathological diagnosis in all nine cases was MCBT. One patient had metastases to a cervical lymph node and lung and another had liver metastasis. The median follow-up period was 3 years (range 6 months to 14 years). Six patients survived surgery, of whom two underwent radiotherapy. Two patients died and one could not be traced.

Entities:  

Mesh:

Year:  2009        PMID: 19863331     DOI: 10.3109/00016480802660510

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  6 in total

1.  Malignant Shamblin III Carotid Body Tumors Resected with Use of the Retrocarotid Dissection Technique in 2 Patients.

Authors:  Carlos A Hinojosa; Javier E Anaya-Ayala; Sandra Olivares-Cruz; Hugo Laparra-Escareno; Alicia Trolle-Silva; Arturo Angeles-Angeles
Journal:  Tex Heart Inst J       Date:  2018-04-07

2.  Multi-institutional survey of carotid body tumors in Japan.

Authors:  Aya Ikeda; Kiyoto Shiga; Katsunori Katagiri; Daisuke Saito; Jun Miyaguchi; Shin-Ichi Oikawa; Kodai Tsuchida; Takahiro Asakage; Hiroyuki Ozawa; Ken-Ichi Nibu; Naoki Ohtsuki; Yasushi Fujimoto; Ken-Ichi Kaneko
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

3.  Carotid Body Tumor Microenvironment.

Authors:  Jean-Paul Bryant; Shelly Wang; Toba Niazi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 4.  Paraganglioma: carotid body tumor.

Authors:  Jacqueline A Wieneke; Alice Smith
Journal:  Head Neck Pathol       Date:  2009-08-23

5.  Bilateral carotid paraganglioma: surgery and radiotherapy.

Authors:  Huriye S Kiziltan; Berke Ozucer; Ali H Eris; Bayram Veyseller
Journal:  Clin Med Insights Case Rep       Date:  2014-07-03

6.  Long-Term Surgical Outcomes of Carotid Body Tumors With Pathological Fibrosis: A Cohort Study.

Authors:  Hanfei Tang; Xiaolang Jiang; Song Xue; Weiguo Fu; Xiao Tang; Daqiao Guo
Journal:  Front Oncol       Date:  2021-07-19       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.